{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:54:32Z","timestamp":1790704472981,"version":"4.1.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T00:00:00Z","timestamp":1544400000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-67101"],"award-info":[{"award-number":["MOP-67101"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-97916"],"award-info":[{"award-number":["MOP-97916"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec \u2013 Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02836","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T05:40:36Z","timestamp":1544420436000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["\u03b22-Glycoprotein I-Reactive T Cells in Autoimmune Disease"],"prefix":"10.3389","volume":"9","author":[{"given":"Joyce","family":"Rauch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Subang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold S.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","article-title":"Pathogenesis of human systemic lupus erythematosus: a cellular perspective","volume":"23","author":"Moulton","year":"2017","journal-title":"Trends Mol Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients","volume":"14","author":"Yaniv","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"17103","DOI":"10.1038\/nrdp.2018.5","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3389\/fimmu.2018.00969","article-title":"Cellular and molecular mechanisms of anti-phospholipid syndrome","volume":"9","author":"Radic","year":"2018","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/art.20120","article-title":"The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus","volume":"50","author":"McClain","year":"2004","journal-title":"Arthritis Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S0002-9343(96)00335-X","article-title":"The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases","volume":"101","author":"Merkel","year":"1996","journal-title":"Am J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/ard.2007.076679","article-title":"Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis","volume":"67","author":"Majka","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3389\/fimmu.2018.00553","article-title":"Novel Concepts of altered Immunoglobulin G galactosylation in autoimmune diseases","volume":"9","author":"Dekkers","year":"2018","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/art.27533","article-title":"Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis","volume":"62","author":"Ercan","year":"2010","journal-title":"Arthritis Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"638129","DOI":"10.1155\/2015\/638129","article-title":"The Pathogenicity of Anti-beta2GP1-IgG autoantibodies depends on Fc glycosylation","volume":"2015","author":"Fickentscher","year":"2015","journal-title":"J Immunol Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1002\/art.39273","article-title":"Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome","volume":"67","author":"Vuckovic","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nrrheum.2015.69","article-title":"The anti-DNA antibody: origin and impact, dogmas and controversies","volume":"11","author":"Rekvig","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6504","DOI":"10.4049\/jimmunol.177.9.6504","article-title":"Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus","volume":"177","author":"Levine","year":"2006","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.thromres.2004.07.017","article-title":"Beta 2 glycoprotein I-function in health and disease","volume":"114","author":"Miyakis","year":"2004","journal-title":"Thromb Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3109\/08916934.2013.783025","article-title":"Antiphospholipid antibodies mediate autoimmunity against dying cells","volume":"46","author":"Andreoli","year":"2013","journal-title":"Autoimmunity"},{"key":"B19","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.4049\/jimmunol.157.5.2201","article-title":"Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner","volume":"157","author":"Price","year":"1996","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/art.40321","article-title":"\u03b22-Glycoprotein I binds to necroptotic cells and serves as a target for SLE autoantibodies","volume":"69","author":"Salem","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1084\/jem.179.4.1317","article-title":"Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes","volume":"179","author":"Casciola-Rosen","year":"1994","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/1756-185X.12568","article-title":"Incomplete clearance of apoptotic cells in systemic lupus erythematosus: pathogenic role and potential biomarker","volume":"18","author":"Jung","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/JIR.S70325","article-title":"Inflammatory etiopathogenesis of systemic lupus erythematosus: an update","volume":"8","author":"Podolska","year":"2015","journal-title":"J Inflamm Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1177\/0961203314548248","article-title":"The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus","volume":"23","author":"Salem","year":"2014","journal-title":"Lupus"},{"key":"B25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.autrev.2015.08.011","article-title":"Delineating the deranged immune system in the antiphospholipid syndrome","volume":"15","author":"van den Hoogen","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coi.2016.09.001","article-title":"T cells in systemic lupus erythematosus","volume":"43","author":"Suarez-Fueyo","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"584374","DOI":"10.1155\/2012\/584374","article-title":"Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus","volume":"2012","author":"Relle","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3389\/fimmu.2018.01088","article-title":"Aberrant T Cell Signaling and subsets in systemic lupus erythematosus","volume":"9","author":"Katsuyama","year":"2018","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrneph.2015.33","article-title":"Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis","volume":"11","author":"Mohan","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/art.1780370819","article-title":"Suppression of experimental antiphospholipid syndrome and systemic lupus erythematosus in mice by anti-CD4 monoclonal antibodies","volume":"37","author":"Tomer","year":"1994","journal-title":"Arthritis Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/art.1780380118","article-title":"Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell","volume":"38","author":"Blank","year":"1995","journal-title":"Arthritis Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1161\/01.CIR.98.11.1108","article-title":"Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I","volume":"98","author":"George","year":"1998","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.4049\/jimmunol.162.11.6919","article-title":"Cellular immunity to beta 2-glycoprotein-1 in patients with the antiphospholipid syndrome","volume":"162","author":"Visvanathan","year":"1999","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/1529-0131(200001)43:1<65::AID-ANR9>3.0.CO;2-I","article-title":"T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals","volume":"43","author":"Hattori","year":"2000","journal-title":"Arthritis Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0198-8859(99)00184-6","article-title":"Analysis of T cell responses to the beta 2-glycoprotein I-derived peptide library in patients with anti-beta 2-glycoprotein I antibody-associated autoimmunity","volume":"61","author":"Ito","year":"2000","journal-title":"Hum Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/0140-6736(90)91374-J","article-title":"Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor","volume":"335","author":"Galli","year":"1990","journal-title":"Lancet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)","volume":"87","author":"McNeil","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1182\/blood.V98.6.1889","article-title":"Autoreactive CD4(+) T-cell clones to beta2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site","volume":"98","author":"Arai","year":"2001","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1182\/blood.V99.7.2499","article-title":"Restricted T-cell receptor beta-chain usage by T cells autoreactive to beta(2)-glycoprotein I in patients with antiphospholipid syndrome","volume":"99","author":"Yoshida","year":"2002","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.1074\/jbc.M114.619817","article-title":"beta2-Glycoprotein I-specific T cells are associated with epitope spread to lupus-related autoantibodies","volume":"290","author":"Salem","year":"2015","journal-title":"J Biol Chem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-018-0013-3","article-title":"T cells from induced and spontaneous models of SLE recognize a common T cell epitope in \u03b22-glycoprotein I","author":"Salem","year":"2018","journal-title":"Cell Mol Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3324\/haematol.2017.170381","article-title":"Patient-derived anti-beta2GP1 antibodies recognize a peptide motif pattern and not a specific sequence of residues","volume":"102","author":"de Moerloose","year":"2017","journal-title":"Haematologica"},{"key":"B43","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/rheumatology\/41.4.395","article-title":"Immune responses to native beta(2)-glycoprotein I in patients with systemic lupus erythematosus and the antiphospholipid syndrome","volume":"41","author":"Davies","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1161\/ATVBAHA.113.302680","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on beta2GPI-specific T cell response","volume":"34","author":"Conti","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1182\/blood-2004-08-3145","article-title":"Binding of beta 2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells","volume":"105","author":"Kuwana","year":"2005","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1182\/blood-2007-07-100008","article-title":"Excessive exposure to anionic surfaces maintains autoantibody response to beta(2)-glycoprotein I in patients with antiphospholipid syndrome","volume":"110","author":"Yamaguchi","year":"2007","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.1182\/blood-2005-03-1201","article-title":"Oxidized beta2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response","volume":"106","author":"Buttari","year":"2005","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1182\/blood-2010-12-325514","article-title":"Advanced glycation end products of human beta(2) glycoprotein I modulate the maturation and function of DCs","volume":"117","author":"Buttari","year":"2011","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/art.10771","article-title":"Valine\/valine genotype at position 247 of the \u03b22-glycoprotein I gene in Mexican patients with primary antiphospholipid syndrome: association with anti-\u03b22-glycoprotein I antibodies","volume":"48","author":"Prieto","year":"2003","journal-title":"Arthritis Rheumatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.humimm.2016.12.008","article-title":"Cellular immune response to beta2-glycoprotein-I valine\/leucine(247) phenotypes in Mexican patients with primary antiphospholipid syndrome","volume":"78","author":"Nunez-Alvarez","year":"2017","journal-title":"Hum Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1002\/art.30383","article-title":"Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen \u03b22-glycoprotein I","volume":"63","author":"Ioannou","year":"2011","journal-title":"Arthritis Rheumatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1538-7836.2011.04301.x","article-title":"Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I","volume":"9","author":"Passam","year":"2011","journal-title":"J Thromb Haemost"},{"key":"B53","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s11926-014-0472-1","article-title":"The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome","volume":"17","author":"Ruff","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"eaan2306","DOI":"10.1126\/scitranslmed.aan2306","article-title":"Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus","volume":"10","author":"Greiling","year":"2018","journal-title":"Sci Transl Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aar7201","article-title":"Translocation of a gut pathobiont drives autoimmunity in mice and humans","volume":"359","author":"Manfredo Vieira","year":"2018","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1056\/NEJMcibr1804368","article-title":"The microbiome and systemic lupus erythematosus","volume":"378","author":"Rosenbaum","year":"2018","journal-title":"N Engl J Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/039463201002300107","article-title":"Beta2-glycoprotein I is a target of T cell reactivity in patients with advanced carotid atherosclerotic plaques","volume":"23","author":"Profumo","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.4049\/jimmunol.1600305","article-title":"Beta2 glycoprotein I recognition drives Th1 inflammation in atherosclerotic plaques of patients with primary antiphospholipid syndrome","volume":"198","author":"Benagiano","year":"2017","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/01.CIR.99.17.2227","article-title":"Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression","volume":"99","author":"George","year":"1999","journal-title":"Circulation"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1161\/01.CIR.102.15.1822","article-title":"Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice","volume":"102","author":"George","year":"2000","journal-title":"Circulation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000028046","article-title":"Enhancement of atherosclerosis in beta-2-glycoprotein I-immunized apolipoprotein E-deficient mice","volume":"67","author":"Afek","year":"1999","journal-title":"Pathobiology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1182\/blood-2004-09-3387","article-title":"IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis","volume":"105","author":"de Laat","year":"2005","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1111\/j.1538-7836.2009.03588.x","article-title":"The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study","volume":"7","author":"de Laat","year":"2009","journal-title":"J Thromb Haemost"},{"key":"B64","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/08916930902828254","article-title":"T cells demonstrate a Th1-biased response to native beta2-glycoprotein I in a murine model of anti-phospholipid antibody induction","volume":"42","author":"Tolomeo","year":"2009","journal-title":"Autoimmunity"},{"key":"B65","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/096120330000900109","article-title":"HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus","volume":"9","author":"Galeazzi","year":"2000","journal-title":"Lupus"},{"key":"B66","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.4049\/jimmunol.161.10.5303","article-title":"Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome","volume":"161","author":"Blank","year":"1998","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.imlet.2018.03.010","article-title":"Effects of Toll-like receptor 4 on beta2-glycoprotein I-induced splenic T cell subsets differentiation","volume":"198","author":"He","year":"2018","journal-title":"Immunol Lett"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02836\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T23:42:17Z","timestamp":1694475737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02836\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,10]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2018.02836"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02836","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,10]]},"article-number":"2836"}}